Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
10/04/2007 | CA2647809A1 Stabilized compositions containing alkaline labile drugs |
10/04/2007 | CA2647801A1 Process for the preparation of a hot-melt extruded laminate |
10/04/2007 | CA2647536A1 Non-homogenous dosage form coatings |
10/04/2007 | CA2647421A1 Sustained release pharmaceutical composition on the basis of a release system comprising an acid-soluble polymer and a ph-dependent polymer. |
10/04/2007 | CA2647123A1 Mucosal bioadhesive slow release carrier for delivering active principles |
10/04/2007 | CA2647109A1 Powder filling processes |
10/04/2007 | CA2646445A1 Granular formulation |
10/04/2007 | CA2646066A1 Use of polymeric materials with other substances for improved performance |
10/04/2007 | CA2644911A1 Antibiotic compositions of modified release and process of production thereof |
10/04/2007 | CA2644616A1 Plant extracts and uses thereof in filter systems |
10/04/2007 | CA2644411A1 Polylactide nanoparticles |
10/04/2007 | CA2642880A1 Stable oral pharmaceutical composition containing thyroid hormone receptor agonists |
10/04/2007 | CA2635281A1 Method of using guava extract and composition including guava extract |
10/04/2007 | CA2631875A1 Formulation of insoluble small molecule therapeutics in lipid-based carriers |
10/04/2007 | CA2583978A1 Surface-modified materials, such as contact lenses, methods and kits for their preparation, and uses thereof |
10/03/2007 | EP1839677A1 Adjuvant of fluorocarbon emulsions for hifu therapy and the use thereof |
10/03/2007 | EP1839665A1 Intraoral disintegration type solid preparation containing povidone iodine |
10/03/2007 | EP1839658A1 Pharmaceutical composition comprising micronized nebivolol |
10/03/2007 | EP1839651A1 Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix |
10/03/2007 | EP1839650A1 Quick disintegration tablet and method of producing the same |
10/03/2007 | EP1839649A1 Coated formulations for tolterodine |
10/03/2007 | EP1839648A2 An inhalation system |
10/03/2007 | EP1839499A1 Composition composed of highly dispersible cellulose complex and polysaccharide |
10/03/2007 | EP1838330A1 Treatment of solid cancers |
10/03/2007 | EP1838318A1 Use of oxycodone for treating visceral pain |
10/03/2007 | EP1838307A1 Methods of using temozolomide formulation intrathecally in the treatment of cancers |
10/03/2007 | EP1838299A1 Pharmaceutical polymer composition for oral controlled-release delivery of terbutaline sulfate |
10/03/2007 | EP1838295A1 Anthelmintic composition |
10/03/2007 | EP1838293A2 Two-piece capsule comprising a preliminary closure for accommodating pharmaceutical preparations for powder inhalers |
10/03/2007 | EP1838292A1 Preparation for preventing or treating calcium deficiency conditions in mammals |
10/03/2007 | EP1838291A2 Pharmaceutical formulations and methods of use |
10/03/2007 | EP1838290A2 Therapeutic peptide formulations for coating microneedles with improved stability containing at least one counterion |
10/03/2007 | EP1838289A1 Controlled release of biological entities |
10/03/2007 | EP1838288A1 Therapeutic materials and methods |
10/03/2007 | EP1838287A1 Process for preparing granulates comprising amoxicillin |
10/03/2007 | EP1838286A2 Production of lipid-based nanoparticles using a dual asymmetrical centrifuge |
10/03/2007 | EP1838285A2 Sustained delivery formulations of octreotide compounds |
10/03/2007 | EP1838284A2 Nanoparticles for delivery of therapeutic agents using ultrasound and associated methods |
10/03/2007 | EP1838283A2 Lipid-based drug delivery systems containing unnatural phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof |
10/03/2007 | EP1838282A1 Aerosol formulation for inhalation containing an anticholinergic agent |
10/03/2007 | EP1838280A2 Personal care compositions |
10/03/2007 | EP1838262A1 Linseed eye compresses |
10/03/2007 | EP1838149A2 Microcapsule |
10/03/2007 | EP1838148A2 Formulation |
10/03/2007 | EP1740214B1 Method of stabilizing disordered cefovecin sodium salt |
10/03/2007 | EP1684726A4 Composition and method for enhancing bioavailability |
10/03/2007 | EP1643977B1 Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form |
10/03/2007 | EP1558219B1 Pharmaceutical formulation of olanzapine |
10/03/2007 | EP1530461B1 Transdermal administration of (r)-3,3-diphenylpropylamine monoesters |
10/03/2007 | EP1455763B1 Oral capsule formulation with increased physical stability |
10/03/2007 | EP1453909B1 Cereal beta glucan compositions, methods of preparation and uses thereof |
10/03/2007 | EP1439828A4 Veterinaire florfenicol formulation that is syringeable under cold weather conditions |
10/03/2007 | EP1355631B1 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor |
10/03/2007 | EP1345597B1 Amphiphilic lipid nanoparticles for peptide and/or protein incorporation |
10/03/2007 | EP1267839B1 Microspheres for active embolization |
10/03/2007 | EP1262490B1 GPib-LIPID BOND CONSTRUCT AND USE THEREOF |
10/03/2007 | EP1244458B1 Weight promoting composition, method, and product |
10/03/2007 | EP1239865B1 Pharmaceutical composition for preventing and treating erectile impotence using purified sumsoo extract |
10/03/2007 | EP1232182B1 Bovine collagen and method for producing recombinant gelatin |
10/03/2007 | EP1227840B1 Adjuvanted genetic vaccines |
10/03/2007 | EP1023081B1 Use of recombinant human uteroglobin in treatment of fibrotic conditions |
10/03/2007 | EP1021084B1 Solution and process for resuscitation and reparation of ischemically damaged tissue |
10/03/2007 | EP0735896B1 Parathyroid hormone formulation |
10/03/2007 | CN200954248Y Asthma acupuncture point therapeutic medicine plaster |
10/03/2007 | CN200954247Y Chinese medicine sticking film with health-care and good-life functions |
10/03/2007 | CN200954246Y Chinese medicine navel therapeutic plaster |
10/03/2007 | CN200954245Y Sore plaster |
10/03/2007 | CN101048498A Virosome particles comprising antigens from influenza virus and hepatitis b virus |
10/03/2007 | CN101048427A Crystallization of antibody or fragment thereof |
10/03/2007 | CN101048226A Use of statistical copolymers as dispersants |
10/03/2007 | CN101048180A Solid formulation with improved solubility and stability, and method for producing said formulation |
10/03/2007 | CN101048179A Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle |
10/03/2007 | CN101048164A Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis |
10/03/2007 | CN101048151A Microprojection array patch for transdermal delivery of vascular endothelial growth factors |
10/03/2007 | CN101048150A 即释型膜包衣 Immediate release film coating |
10/03/2007 | CN101048149A Solid pharmaceutical preparation dissolved in oral cavity |
10/03/2007 | CN101048148A Dosage forms having a microreliefed surface and methods and apparatus for their production |
10/03/2007 | CN101048147A Dosage forms having a microreliefed surface and methods and apparatus for their production |
10/03/2007 | CN101048146A Dosage forms having a microreliefed surface and methods and apparatus for their production |
10/03/2007 | CN101048145A Dosage forms having a microreliefed surface and methods and apparatus for their production |
10/03/2007 | CN101048144A Dosage forms having a microreliefed surface and methods and apparatus for their production |
10/03/2007 | CN101048143A Dosage forms having a microreliefed surface and methods and apparatus for their production |
10/03/2007 | CN101048142A Dosage forms having a microreliefed surface and methods and apparatus for their production |
10/03/2007 | CN101048141A Process for forming amorphous atorvastatin |
10/03/2007 | CN101048140A Novel pharmaceutical compositions for the treatment of cancer |
10/03/2007 | CN101048139A Compositions for controlled delivery of pharmaceutically active compounds |
10/03/2007 | CN101048138A Use of liposomal glucocorticoids for treating inflammatory states |
10/03/2007 | CN101048137A Spontaneously dispersible pharmaceutical compositions |
10/03/2007 | CN101048136A Microemulsion and sub-micron emulsion process and compositions |
10/03/2007 | CN101048135A Phenolic antiseptic compositions and methods of use |
10/03/2007 | CN101045166A Pulmonary administration of chemically modified insulin |
10/03/2007 | CN101045158A Insulin analog dry powder composition and its preparing method |
10/03/2007 | CN101045157A Method for preparing high activity, soluble, recombination human endothelial chalone injection |
10/03/2007 | CN101045152A Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease concomitant inflammatory swelling |
10/03/2007 | CN101045151A Traditional Chinese medicine composition for treating climacteric metancholia and its preparing process |
10/03/2007 | CN101045150A Application of compound preparation in medical composition for tonifying-kidney, strengthening body and invigorating-brain |
10/03/2007 | CN101045149A Medicine composition and its preparing method |
10/03/2007 | CN101045148A Ointment for treating anaphylactic and its producing method |
10/03/2007 | CN101045147A Traditional Chinese medicine composition, its preparing method and use |
10/03/2007 | CN101045142A Medicine for treating foot tinea and hand tinea |